Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis
Authors
Keywords
Hepatitis C virus, Mutagenesis, Guanosine, DNA sequence analysis, RNA sequence analysis, Cell cultures, Amino acid sequence analysis, Extinct genomes
Journal
PLoS One
Volume 8, Issue 8, Pages e71039
Publisher
Public Library of Science (PLoS)
Online
2013-08-17
DOI
10.1371/journal.pone.0071039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model
- (2013) Clara Ramírez et al. ANTIVIRAL RESEARCH
- Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients
- (2013) J. Dietz et al. JOURNAL OF VIROLOGY
- Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
- (2013) C. Perales et al. JOURNAL OF VIROLOGY
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
- (2013) T. Baranovich et al. JOURNAL OF VIROLOGY
- Destabilization of PDK1 by Hsp90 inactivation suppresses hepatitis C virus replication through inhibition of PRK2-mediated viral RNA polymerase phosphorylation
- (2012) Mi-Gyeong Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ribavirin-induced intracellular GTP depletion activates transcription elongation in coagulation Factor VII gene expression
- (2012) Atsuo Suzuki et al. BIOCHEMICAL JOURNAL
- Is There a Role for Ribavirin in the Era of Hepatitis C Virus Direct-Acting Antivirals?
- (2012) Jordan J. Feld GASTROENTEROLOGY
- New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets
- (2012) Alexander Ploss et al. GUT
- Viral Quasispecies Evolution
- (2012) E. Domingo et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Mutagenesis-Mediated Virus Extinction: Virus-Dependent Effect of Viral Load on Sensitivity to Lethal Defection
- (2012) Héctor Moreno et al. PLoS One
- The impact of quasispecies dynamics on the use of therapeutics
- (2012) Celia Perales et al. TRENDS IN MICROBIOLOGY
- Back to the future: revisiting HIV-1 lethal mutagenesis
- (2012) Michael J. Dapp et al. TRENDS IN MICROBIOLOGY
- Mutagen-mediated enhancement of HIV-1 replication in persistently infected cells
- (2012) Carmen Sánchez-Jiménez et al. VIROLOGY
- Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells
- (2012) Li Ye et al. VIRUS RESEARCH
- Ribavirin efficiently suppresses porcine nidovirus replication
- (2012) Youngnam Kim et al. VIRUS RESEARCH
- Arenaviruses and Lethal Mutagenesis. Prospects for New Ribavirin-based Interventions
- (2012) Héctor Moreno et al. Viruses-Basel
- Mutation Induced Extinction in Finite Populations: Lethal Mutagenesis and Lethal Isolation
- (2012) C. Scott Wylie et al. PLoS Computational Biology
- Visualization and Measurement of ATP Levels in Living Cells Replicating Hepatitis C Virus Genome RNA
- (2012) Tomomi Ando et al. PLoS Pathogens
- Lethal mutagenesis, error thresholds, and the fight against viruses: Rigorous modeling is facilitated by a firm physical background
- (2011) Peter Schuster COMPLEXITY
- Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo
- (2011) Qiuwei Pan et al. HEPATOLOGY
- Lethal Mutagenesis of Foot-and-Mouth Disease Virus Involves Shifts in Sequence Space
- (2011) C. Perales et al. JOURNAL OF VIROLOGY
- Ribavirin Can Be Mutagenic for Arenaviruses
- (2011) H. Moreno et al. JOURNAL OF VIROLOGY
- Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genome
- (2011) M. Homs et al. NUCLEIC ACIDS RESEARCH
- Mutation of HIV-1 Genomes in a Clinical Population Treated with the Mutagenic Nucleoside KP1461
- (2011) James I. Mullins et al. PLoS One
- Tempo and mode of inhibitor-mutagen antiviral therapies: A multidisciplinary approach
- (2011) J. Iranzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New Insights into the HCV Quasispecies and Compartmentalization
- (2011) Patrizia Farci SEMINARS IN LIVER DISEASE
- Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system
- (2011) Kyoko Mori et al. VIRUS RESEARCH
- Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy
- (2010) C. M. Lange et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Functions and Regulation of RNA Editing by ADAR Deaminases
- (2010) Kazuko Nishikura Annual Review of Biochemistry
- Ribavirin Improves Early Responses to Peginterferon Through Improved Interferon Signaling
- (2010) Jordan J. Feld et al. GASTROENTEROLOGY
- Unfinished Stories on Viral Quasispecies and Darwinian Views of Evolution
- (2010) Antonio Más et al. JOURNAL OF MOLECULAR BIOLOGY
- Occult hepatitis C virus infection: what does it mean?
- (2010) Tram N. Q. Pham et al. LIVER INTERNATIONAL
- Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
- (2010) Christopher T Jones et al. NATURE BIOTECHNOLOGY
- Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies
- (2010) Osvaldo Zagordi et al. NUCLEIC ACIDS RESEARCH
- Lethal Mutagenesis: Targeting the Mutator Phenotype in Cancer
- (2010) Edward J. Fox et al. SEMINARS IN CANCER BIOLOGY
- Ribavirin Plasma Concentration Measurements in Patients With Hepatitis C: Early Ribavirin Concentrations Predict Steady-State Concentrations
- (2010) Serena Slavenburg et al. THERAPEUTIC DRUG MONITORING
- Mixing the right hepatitis C inhibitor cocktail
- (2010) Michael A. Gelman et al. TRENDS IN MOLECULAR MEDICINE
- A Multi-Step Process of Viral Adaptation to a Mutagenic Nucleoside Analogue by Modulation of Transition Types Leads to Extinction-Escape
- (2010) Rubén Agudo et al. PLoS Pathogens
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Lethal Mutagenesis in Viruses and Bacteria
- (2009) P. Chen et al. GENETICS
- 5-Azacytidine Can Induce Lethal Mutagenesis in Human Immunodeficiency Virus Type 1
- (2009) M. J. Dapp et al. JOURNAL OF VIROLOGY
- Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
- (2009) J. M. Cuevas et al. JOURNAL OF VIROLOGY
- Counteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic Treatment
- (2009) Celia Perales et al. PLoS One
- Potential Benefits of Sequential Inhibitor-Mutagen Treatments of RNA Virus Infections
- (2009) Celia Perales et al. PLoS Pathogens
- Topology of evolving, mutagenized viral populations: quasispecies expansion, compression, and operation of negative selection
- (2008) Samuel Ojosnegros et al. BMC EVOLUTIONARY BIOLOGY
- Therapeutically targeting RNA viruses via lethal mutagenesis
- (2008) Jason D Graci et al. Future Virology
- Occult hepatitis C: How convincing are the current data?
- (2008) Martin-Walter Welker et al. HEPATOLOGY
- Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells
- (2008) Svetlana Marukian et al. HEPATOLOGY
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
- (2008) Thomas Kuntzen et al. HEPATOLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient
- (2007) Maria Cubero et al. VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now